SCHEMBL6746550

SCHEMBL6746550

CCCc1c(C(=O)NCc2nccs2)n(N)c2ccccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 1/20 0.41
PDE10A Q9Y233 1/20 0.38
PSMD14 O00487 1/20 0.38
STAMBP O95630 1/20 0.38
COPS5 Q92905 1/20 0.38
KCNK3 O14649 3/20 0.38
PIK3CA P42336 1/20 0.37
ALDH1A1 P00352 3/20 0.37
KDM4E B2RXH2 3/20 0.37
LMNA P02545 2/20 0.37
TSHR P16473 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
USP2 O75604 1/20 0.37
TP53 P04637 1/20 0.37
MAPT P10636 1/20 0.37
HTT P42858 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
NAPEPLD Q6IQ20 1/20 0.37
MAPK1 P28482 2/20 0.36
HPGD P15428 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7044113 0.84 ALDH1A1 (0.52) ALDH1A1KDM4ELMNATSHRSMN1; SMN2
SCHEMBL4611362 0.78 TP53 (0.52) ALDH1A1KDM4ELMNASMN1; SMN2TP53
SCHEMBL6746555 0.78 KDM4E (0.47) NTRK1KCNK3ALDH1A1KDM4ELMNA
SCHEMBL4610877 0.78 KMT2A (0.51) ALDH1A1KDM4ELMNASMN1; SMN2MAPT
SCHEMBL4613206 0.76 MEN1 (0.41) PDE10AALDH1A1KDM4ELMNATSHR
SCHEMBL4612617 0.75 MEN1 (0.52) ALDH1A1KDM4ETSHRTP53HTT
SCHEMBL7047164 0.75 CA2 (0.52) ALDH1A1MAPTKMT2AALOX15
SCHEMBL7039562 0.73 RORC (0.54) ALDH1A1ALOX15
SCHEMBL7046082 0.72 P2RX7 (0.44) KDM4ESMN1; SMN2KMT2ANPC1RAB9A
SCHEMBL7046652 0.72 P2RX7 (0.47) KDM4ESMN1; SMN2MEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040235833-A1 Indole derivatives useful for the treatment of diseases PFIZER INC 2004-11-25 US claimed
EP-1460064-A1 Indole-2-carboxamide derivatives useful as beta-2 agonists Pfizer Limited (GB) 2004-09-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040235833-A1 Indole derivatives useful for the treatment of diseases IDO1, IDO2, INMT NTRK1 3368/4885PDE10A 2570/4885PSMD14 4148/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.